La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company has several product candidates in development. LJPC-501 is La JollaUas proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension.
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of S. Coyle at La Jolla Pharmaceutical then you’ve come to the right place.
Wondering if it's s.@ljpc.com, s..coyle@ljpc.com, coyle@ljpc.com, or scoyle@ljpc.com? We have the answers for you.